The Walter and Eliza Hall Institute Announces the Next Director
Announcing Professor Hilton’s appointment as Director-Designate, the President of the Board, Mr.
Mr. Davis said that the recruitment and selection group, which was chaired by WEHI Board member,
Professor Hilton, 44, will be the sixth Director of WEHI in its ninety-four year history and will take up his appointment from
Professor Hilton will succeed current WEHI Director, Professor
Upon receiving news of his appointment, Professor Hilton said that he was delighted to be entrusted with the leadership of one of the world’s leading medical research institutes. He said that to join the ranks of the Institute’s leaders, alongside
Professor Hilton said that he was acutely conscious of the prodigious efforts and achievements of current and past Directors, scientists and support staff, who had created the pre-eminent worldwide reputation of the Institute.
To assure such ongoing success of the Institute, Professor Hilton believes:
* The Institute must build on its tradition of forming collaborative teams that are close-knit, trans-generational and outcomes-focused, to tackle health questions of major importance
* The Institute must forge even stronger links with clinical colleagues at the Royal Melbourne Hospital, the Royal Women’s Hospital, the Royal Children’s Hospital the Peter MacCallum Cancer Centre and elsewhere.
* Collaborations with the private sector, both in
* Cancer, blood cell research, immunology, autoimmunity and infectious diseases will remain cornerstones of the Institute’s endeavours.
* The Institute must continue to pursue well-considered technological and investigative innovations such as the successful Cory-era developments of structural biology, chemistry, high-throughput screening, and mathematics and computational science
* The Institute should consider, in collaboration with indigenous communities and other organizations, how to play a constructive role in improving indigenous health.
Professor Hilton has received many prizes and awards for his contribution to medical research, including the Amgen Medical Researcher Award, the inaugural Commonwealth Health Minister’s Award for Excellence in Health and Medical Research and the GSK Australia Award for Research Excellence.
At the age of just 39 he was elected a Fellow of the Australian Academy of Science and currently serves on this organization’s Council. In 2008, he was recognized as one of the NHMRC’s “Ten great minds in health and medical research.”
Throughout his career, Professor Hilton has been actively involved in the application of research through collaboration with industry. He is an inventor on more than twenty patent families, most of which have been licensed. He co-founded the biotechnology company Murigen and actively collaborates with CSL on a number of projects.
After his PhD, Hilton spent two formative years as a postdoctoral fellow at the Whitehead Institute,
Since returning to
In recent years, together with
Pic available: Professor
The image is for use by the media, courtesy of WEHI.
Professor Hilton is available for interview.
Further information: Brad Allan Communications Manager, WEHI tel +61 3 9345 2345 mob +61 403 036 116
SOURCE The Walter and Eliza Hall Institute of Medical Research